VYXEOS (daunorubicin and cytarabine) liposome for injection

VYXEOS is a prescription medicine used to treat acute myeloid leukemia (t-AML) or AML. FDA approved abaloparatide (brand name VYXEOS) is not (yet) registered or available in India but on request Indian patient can buy VYXEOS at the lowest price.

VYXEOS (Daunorubicin/cytarabin) injection Price Delhi India
VYXEOS (daunorubicin and cytarabine) liposome for injection

Submit a request to access drug used to treat, diagnose or prevent serious or life-threatening conditions.We’ll get back to you within 1 business days!

For Indian Patient Enquiry under NPP.

For any urgent inquiries or assistance needed, please reach out to our Support Team. Rest assured, we will respond within 24 hours, from Monday to Saturday, during the hours of 9:00 A.M to 18:00 PM.

VYXEOS (daunorubicin and cytarabine) liposome for injection

Daunorubicin/cytarabine, is a fixed-dose combination medication used for the treatment of acute myeloid leukemia

VYXEOS is a liposomal combination of daunorubicin, an anthracycline topoisomerase inhibitor, and cytarabine, a nucleoside metabolic inhibitor, that is indicated for the treatment of adults with newly-diagnosed therapy-related acute myeloid leukemia (t-AML) or AML with myelodysplasia-related changes (AML-MRC).

Daunorubicin/cytarabine, sold under the brand name Vyxeos, is a fixed-dose combination medication used for the treatment of acute myeloid leukemia. It contains the liposomal bound daunorubicin, an anthracycline topoisomerase inhibitor, and cytarabine, a nucleoside metabolic inhibitor. Daunorubicin/cytarabine is indicated for the treatment of newly-diagnosed therapy-related acute myeloid leukemia (t-AML) or AML with myelodysplasia-related changes (AML-MRC) in people aged one year of age and older.

VYXEOS (daunorubicin and cytarabine) liposome for injection, for intravenous use Initial U.S. Approval: 2017
—————-
Current Indication: Treat acute myeloid leukemia (t-AML) or AML
—————-
Marketed By: Jazz Pharmaceuticals, Inc.
—————-
Approval Date: : 2017
—————-
Active ingredients:daunorubicin and cytarabine
—————-
Inactive ingredients: polysorbate 20, sodium succinate, succinic acid, and sucrose

For injection: 44 mg daunorubicin and 100 mg cytarabine encapsulated in liposomes as a lyophilized cake in a single-dose vial for reconstitution

For more highlights of prescribing information regarding Indications and usage, dosage and administration, dosage forms and strengths, patient counseling information and medication guide. Click Here

Alleviare Life Sciences

About Us

Alleviare Life Sciences Pvt. Ltd. (India) serves as a facilitator for medical and pharmaceutical products, commencing its operations in 2005. Headquartered in Delhi, India, Alleviare operates nationwide, providing a range of comprehensive services to patients, doctors, hospitals, and government healthcare facilities.

Our specialization lies in facilitating access to medicines, leveraging our expertise in sourcing and providing documentation assistance for programs such as Named Patient Program, Managed Access Program, and Early Access Program. We take pride in ensuring smooth and efficient access to medications for those who require them.

Alleviare India, a certified pharmaceutical facilitator / supplier / importer of specialty medicines or drugs based in India.